John Oluwafemi Teibo: Excited to share our latest publication on the molecular effectors of the CAR-T Cell therapy in Cancer Management
John Oluwafemi Teibo, Membership Associate at Royal Society of Chemistry, shared a post on LinkedIn:
“Excited to share our latest publication where we explored proteomics outlook on the molecular effectors of the CAR-T Cell therapy in Cancer Management.
Many thanks to my supervisors: Vitor Faça, Virginia Picanço and Lucas E. Botelho de Souza for this piece.
A Proteomics Outlook on the Molecular Effectors of CAR-T Cell Therapy in Cancer Management
Authors: John Oluwafemi Teibo, Virginia Picanço-Castro, Lucas Eduardo Botelho de Souza, Vitor Marcel Faça
This study was supported by FAPESP, CAPES – Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Royal Society of Chemistry, International Union of Biochemistry and Molecular Biology (IUBMB), Biochemical Society, European Association for Cancer Research (EACR), CTC USP, Hemocentro de Ribeirão Preto and CNPq.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023